Breaking News Instant updates and real-time market news.

ANGI

Angie's List

$5.78

0.04 (0.70%)

11:31
02/17/17
02/17
11:31
02/17/17
11:31

Angies List attracts a large option block as shares extend recent losses

Angies List attracts a large option block as shares extend recent losses. The stock, which lost 9% on earnings two days ago, is off 20c to $5.58 and 15K Mar 5 puts are opened for 45c when the bid-ask was 30 to 45c. The block is tied to 450K shares and will open open interest in the name, surpassing the 5K of expiring OI in Feb 10 puts.

ANGI Angie's List
$5.78

0.04 (0.70%)

01/17/17
COWN
01/17/17
NO CHANGE
Target $7
COWN
Market Perform
Cowen loses confidence Angie's List can secure favorable takeout terms
Cowen analyst Kevin Kopelman noted Angie's List (ANGI) released in-line membership numbers, but said the lack of details on more meaningful metrics was a negative. He said he is less confident the company can secure a favorable deal outcome with IAC (IAC). Kopelman maintained his Market Perform rating on Angie's List and lowered his price target to $6.50 from $9.00 as he discounted the probability of a favorable deal outcome.
02/16/17
LOOP
02/16/17
NO CHANGE
Target $9
LOOP
Buy
Angie's List turnaround taking longer than expected, says Loop Capital
Loop Capital analyst Blake Harper said the turnaround at Angie's List has been "promising," but slower than expected, adding that he thinks revenue growth is not likely to return until the second half of this year. He cut his estimates to reflect the slower turnaround and lowered his price target to $9 from $12 in turn. He keeps a Buy rating on Angie's, as he believes the company is likely to find a strategic partner or acquirer, but adds that it needs to show some improvement to achieve a "suitable" deal price.
02/16/17
ROTH
02/16/17
DOWNGRADE
Target $4.75
ROTH
Sell
Angie's List downgraded to Sell from Neutral at Roth Capital
Roth Capital analyst Darren Aftahidowngraded Angie's List to Sell and lowered his price target for the shares to $4.75 from $6.50 following the company's Q4 results.
02/16/17
02/16/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Regeneron (REGN) downgraded to Neutral from Buy at Goldman by analyst Terence Flynn, citing valuation with the stock within 9% of his unchanged $417 price target. The analyst sees less upside potential relative to Regeneron's large-cap peers Amgen (AMGN) and Alexion (ALXN), he said. 2. GoDaddy (GDDY) downgraded to Hold from Buy at Summit Redstone by analyst Jonathan Kees, who notes that management brought down growth expectations for its three segments. Kees believes the integration of HEG may be long as personnel need to be trained on GoDaddy products, sales, and service before market expansion begins and believes shares could pullback similar to Web.com (WEB) and Endurance (EIGI) as they went through their acquisitions. 3. Wells Fargo (WFC) downgraded to Neutral at Credit Suisse by analyst Susan Roth Katzke, citing valuation. 4. Angie's List (ANGI) downgraded to Sell from Neutral at Roth Capital by analyst Darren Aftahi, who lowered his price target for the shares to $4.75 from $6.50 following the company's Q4 results. 5. Groupon (GRPN) downgraded to Neutral from Outperform at Wedbush by analyst Aaron Turner, saying shares have achieved his $4.50 price target. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

KMB

Kimberly-Clark

$113.44

-2.11 (-1.83%)

07:30
10/23/17
10/23
07:30
10/23/17
07:30
Earnings
Kimberly-Clark reports Q3 EPS $1.60, consensus $1.54 »

Reports Q3 revenue $4.6B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

WFT

Weatherford

$3.54

-0.16 (-4.32%)

, BSX

Boston Scientific

$29.69

0.12 (0.41%)

07:30
10/23/17
10/23
07:30
10/23/17
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

WFT

Weatherford

$3.54

-0.16 (-4.32%)

BSX

Boston Scientific

$29.69

0.12 (0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

  • 01

    Nov

  • 06

    Nov

VFC

VF Corp.

$66.38

1.03 (1.58%)

07:29
10/23/17
10/23
07:29
10/23/17
07:29
Technical Analysis
Technical View: VF Corp. hits fresh 52-week high after earnings beat »

The stock was last at $69…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

HAS

Hasbro

$98.19

1.52 (1.57%)

07:28
10/23/17
10/23
07:28
10/23/17
07:28
Earnings
Hasbro sees Q4 revenue up 4%-7%, consensus $1.82B »

"The quarter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

SALT

Scorpio Bulkers

$8.20

0.45 (5.81%)

07:28
10/23/17
10/23
07:28
10/23/17
07:28
Earnings
Scorpio Bulkers reports Q3 GAAP EPS (15c), consensus (13c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

ALGN

Align Technology

$200.88

4.03 (2.05%)

07:28
10/23/17
10/23
07:28
10/23/17
07:28
Recommendations
Align Technology analyst commentary  »

Align Technology price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

  • 06

    Nov

FL

Foot Locker

$31.28

0.29 (0.94%)

07:27
10/23/17
10/23
07:27
10/23/17
07:27
Downgrade
Foot Locker rating change  »

Foot Locker downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

07:27
10/23/17
10/23
07:27
10/23/17
07:27
Recommendations
DBV Technologies analyst commentary  »

Barclays cuts DBV target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DEL

Deltic Timber

$89.12

0.98 (1.11%)

07:27
10/23/17
10/23
07:27
10/23/17
07:27
Hot Stocks
Breaking Hot Stocks news story on Deltic Timber »

Deltic Timber jumps 7% in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

ROKU

Roku

$21.87

-0.16 (-0.73%)

07:25
10/23/17
10/23
07:25
10/23/17
07:25
Initiation
Roku initiated  »

Roku initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

TSRO

Tesaro

$116.40

0.89 (0.77%)

, CLVS

Clovis

$77.50

0.73 (0.95%)

07:24
10/23/17
10/23
07:24
10/23/17
07:24
Initiation
Tesaro, Clovis initiated  »

Tesaro initiated with an…

TSRO

Tesaro

$116.40

0.89 (0.77%)

CLVS

Clovis

$77.50

0.73 (0.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 06

    Nov

  • 08

    Nov

NCNA

NuCana

$14.08

-0.3 (-2.09%)

07:23
10/23/17
10/23
07:23
10/23/17
07:23
Initiation
NuCana initiated  »

NuCana initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:23
10/23/17
10/23
07:23
10/23/17
07:23
General news
Futures higher ahead of buy week of earnings »

Stock futures are…

AIMT

Aimmune

$25.66

-0.06 (-0.23%)

, DBVT

DBV Technologies

$48.07

0.92 (1.95%)

07:23
10/23/17
10/23
07:23
10/23/17
07:23
Recommendations
Aimmune, DBV Technologies analyst commentary  »

Aimmune price target…

AIMT

Aimmune

$25.66

-0.06 (-0.23%)

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

FL

Foot Locker

07:23
10/23/17
10/23
07:23
10/23/17
07:23
Downgrade
Foot Locker rating change  »

Foot Locker downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TXN

Texas Instruments

$95.18

1.73 (1.85%)

07:23
10/23/17
10/23
07:23
10/23/17
07:23
Recommendations
Texas Instruments analyst commentary  »

Texas Instruments price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

JPM

JPMorgan

$99.51

1.4 (1.43%)

07:22
10/23/17
10/23
07:22
10/23/17
07:22
Periodicals
JPMorgan, Mosaic Smart Data partner to boost fixed-income trading, Reuters says »

JPMorgan has teamed up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 02

    Nov

  • 05

    Nov

  • 27

    Feb

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

CLVS

Clovis

$77.50

0.73 (0.95%)

07:21
10/23/17
10/23
07:21
10/23/17
07:21
Initiation
Clovis initiated  »

Clovis initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

BIIB

Biogen

$338.10

-4.32 (-1.26%)

, ESALY

Eisai

$53.38

-0.25 (-0.47%)

07:19
10/23/17
10/23
07:19
10/23/17
07:19
Hot Stocks
Biogen, Eisai expand existing collaboration agreement »

Eisai Co., Ltd. (ESALY)…

BIIB

Biogen

$338.10

-4.32 (-1.26%)

ESALY

Eisai

$53.38

-0.25 (-0.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 25

    Oct

NITE

Nightstar Therapeutics

$19.00

-0.1 (-0.52%)

07:19
10/23/17
10/23
07:19
10/23/17
07:19
Initiation
Nightstar Therapeutics initiated  »

Nightstar Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCH

Potlatch

$53.00

-0.35 (-0.66%)

07:18
10/23/17
10/23
07:18
10/23/17
07:18
Earnings
Potlatch reports Q3 EPS ex-items 94c, consensus 90c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

PCH

Potlatch

$53.00

-0.35 (-0.66%)

07:18
10/23/17
10/23
07:18
10/23/17
07:18
Hot Stocks
Potlatch raises dividend to 40c per share from 37.5c per share »

Potlatch announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

SAIC

SAIC

$70.88

1.04 (1.49%)

07:18
10/23/17
10/23
07:18
10/23/17
07:18
Upgrade
SAIC rating change  »

SAIC upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

GGB

Gerdau

07:17
10/23/17
10/23
07:17
10/23/17
07:17
Initiation
Gerdau initiated  »

Gerdau resumed with a Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VALE

Vale

07:17
10/23/17
10/23
07:17
10/23/17
07:17
Initiation
Vale initiated  »

Vale resumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.